Bleeding risk Omega-3 fatty acids are generally safe, but they can have side effects when consumed in high doses. One ...
The 2021 approval by regulatory agencies of belimumab, a B lymphocyte stimulator (BLyS) inhibitor, and the 2022 approval of anifrolumab, a type I interferon inhibitor, has increased the therapeutic ...